BVS – bioventus inc. - class a (US:NASDAQ)
Stock Stats
News
Pressure Ulcers Treatment Markets, 2024-2028 & 2033 [Yahoo! Finance]
Bioventus Inc. (NYSE: BVS) had its price target raised by analysts at Canaccord Genuity Group Inc. from $12.00 to $15.00. They now have a "buy" rating on the stock.
Bioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... [Yahoo! Finance]
Bioventus (BVS) Matches Q3 Earnings Estimates [Yahoo! Finance]
Bioventus: Q3 Earnings Snapshot [Yahoo! Finance]
Form SCHEDULE 13G/A Bioventus Inc. Filed by: Nantahala Capital Management, LLC
Form SC 13G/A Bioventus Inc. Filed by: Spindletop Healthcare Capital, L.P.
Form 10-Q Bioventus Inc. For: Sep 28
Form 8-K Bioventus Inc. For: Nov 05
Form EFFECT Bioventus Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.